Harvest Health & Recreation (CSE:HARV,OTCQX:HRVSF), a major US-based cannabis multi-state operator (MSO), is expanding its footprint in Maryland.

The Arizona-based cannabis firm announced on Wednesday (September 11) it signed a state-approved management services agreement with Your Farmacy-CWS, a medical cannabis dispensary in Lutherville-Timonium, Maryland.


The 3,120 square foot Your Farmacy location will be transitioned into a Harvest House to join the company’s other Harvest dispensary and cultivation facility in the state.

In a press release, the company said this move will further establish Harvest Health as a cannabis operator on the east coast, adding to its presence in the western US.

Harvest executive chairman Jason Vedadi said in a statement the company will expand Your Farmacy’s existing services for patients.

With this transaction, Harvest now holds licenses for over 210 facilities in 18 states — about 130 of which are retail locations.

This news follows another of the MSO’s east coast expansions, this time in Florida as it opened its sixth dispensary in the state last month.

Maryland’s cannabis industry has made strides since a law was passed to expand medical marijuana in the state in 2014. Sales of the drug, however, didn’t start until 2017, when dispensaries began to open after years of bureaucratic delays.

The medical marijuana landscape looks much different now, though. Data from the Maryland Medical Cannabis Commission, the state’s marijuana regulator, reported that from July 2018 to July of this year, over 26,000 pounds of cannabis flower had been sold. In that same span of time, over 1.8 million cannabis-infused products were purchased and there was more than US$203 million in dispensary sales.

Maryland has almost 77,000 certified medical marijuana patients and over 1,500 cannabis providers as of Tuesday (September 10) and, as of July, the mid-Atlantic state houses over 80 cannabis dispensaries.

Other cannabis firms have taken notice of the rapid growth.

According to an article in the Washington Post, the state’s cultivators are doubling production to meet increasing demand for the drug and positioning themselves for the possibility of full legalization.

The legalization of cannabis for adult use has been a point of discussion in Maryland. In June, a Maryland General Assembly task force began studying the issue and may complete its work by the end of this year, according to the Baltimore Sun.

Harvest’s results for the second quarter of its fiscal year for 2019 saw total revenues at US$$26.6 million, up from the US$19.2 million reported in Q1 Of 2019. Net losses were at US$20.6 million, which the company attributed to its planned infrastructure investments.

Harvest Health shares dropped over the course of the trading day, falling almost 4.7 percent from C$7.08 to C$6.75 as of 3:25 p.m. EDT.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

Keep reading... Show less